Beyond protection: Turning patent portfolios into commercial advantage

​
November 12, 2026

Why the strongest patent strategies begin with business value - not patent volume

The proposition

A patent portfolio can be legally impressive and commercially disappointing. The real test is not how many patents a business owns, but what those patents enable it to do. For many organisations, patents are still viewed primarily as defensive legal tools. But in today’s innovation-driven economy, the strongest portfolios do much more: they support growth, investment, partnerships, valuation and competitive advantage.

Patents remain important defensive rights. They can deter copying, create barriers to entry and provide leverage when a competitor gets too close. But protection is only the starting point. A portfolio creates real value when it is connected deliberately to the company’s products, markets, funding strategy and commercial relationships. Without that connection, even technically strong patents can become an expensive record of past innovation.

1. A patent is not valuable merely because it has been granted

A grant certificate proves that a legal threshold has been met. It does not prove that the patent protects a product customers want, covers a commercially important market or would survive a determined validity challenge.

That distinction matters because patents are expensive throughout their life. Filing, prosecution, overseas protection, translations, renewals and enforcement all compete for capital. The objective should not be to accumulate rights, but to build a portfolio whose scope, ownership and geographic coverage support a credible commercial position.

Nor is quantity a reliable proxy for strength. Five well-chosen patent families may do more for a business than fifty peripheral filings. Value depends on what the claims cover, how difficult they are to design around, whether the rights align with the market and whether the business can use them in practice.

The strongest portfolios are built with the end goal in mind from the beginning.

2. Start with the commercial objective

In my experience, the most productive patent discussions begin not with “Can we patent this?” but with “What commercial position are we trying to create?”

That question changes the conversation. It requires the business to identify the products and services that matter, the markets it expects to enter, the competitors or partners it may encounter and the capabilities that genuinely differentiate it. Filing decisions can then be tested against those objectives rather than driven by technical novelty alone.

This is critical in deep tech: quantum, artificial intelligence, life sciences, semiconductors and advanced engineering, where technologies and business models can evolve faster than the patent process. The portfolio must move with the business - not anchor it to an obsolete roadmap.

3. Use patents to create options: investment, licensing and partnerships

The commercial power of a patent is often its ability to create options. For an investor or acquirer, a coherent portfolio can evidence ownership, technical differentiation and a disciplined approach to future growth. It can support valuation, although it does not determine valuation on its own.

Patents can also make collaboration easier. Clearly defined rights help parties understand what each is bringing to a joint development, what access is required and how resulting technology may be commercialised. That clarity can reduce friction in negotiations with larger industrial partners, research institutions and other members of an innovation ecosystem.

Licensing adds another route to value. A business need not manufacture every product or enter every territory itself. Rights that are peripheral to one company’s strategy may be central to another’s. But licensing revenue is not automatic: it depends on market demand, useful claim scope, credible ownership and a counterparty with a commercial reason to take a licence.

4. Review ruthlessly: quality, relevance and cost

A portfolio should not be treated as a museum. Products change, markets close, competitors move and once-promising technologies lose relevance. Regular review is therefore as important as initial filing.

Each patent family should earn its place. Does it still support a current or credible future product? Is the protected market important? Does the right constrain a competitor, strengthen a negotiation or offer a realistic licensing opportunity? Are the likely benefits proportionate to the next round of prosecution and renewal costs?

Where the answer is no, sale, licensing or abandonment may be the disciplined choice. Pruning is not a sign that the original filing failed. It is evidence that the portfolio is being managed as a business asset.

5. Protection is only one part of the IP strategy

A balanced and credible strategy also recognises what patents cannot do. Patent ownership does not establish freedom to operate: a business may own valuable rights and still risk infringing an earlier third-party patent. Nor is patenting always the best answer. Filing requires disclosure, enforcement can be costly and some innovations are better protected through confidentiality, accumulated know-how, contractual controls, data advantages or speed to market.

The right question is therefore not whether patents are inherently valuable. It is where they add value relative to the alternatives. For some technologies, a patent will be the foundation of market exclusivity. For others, it will be one element in a broader package of rights and practical barriers that competitors cannot easily reproduce.

6. Conclusion: make the portfolio work for the business

The strongest patent strategies are neither filing exercises nor defensive reflexes. They are commercial disciplines. They connect protection decisions to products, markets, capital, partnerships and competitive choices - and they change when the business changes.

That means filing selectively, documenting ownership, reviewing the portfolio honestly and being clear about the outcome each right is intended to support. It also means recognising when another form of protection would serve the business better.

The goal is not simply to own patents. The goal is to make the portfolio work for the business.

Turn your patent portfolio into a commercial asset

Looking to get more value from your patents? Talk to our team about developing a patent strategy aligned with your commercial ambitions.

The Latest Thought Leadership pieces in the Content Hub

No items found.
Stay in the Know

The Patent Strategist

Get expert insights and the top patent stories delivered straight to your inbox.

Heading
This is some text inside of a div block.
This is some text inside of a div block.

Latest Insights

Showing 0 of 100
Provisional Agreement Reached on the EU Pharma Package: Takeaways for Pharmaceutical Companies
17 February 2026
The EU’s new Pharma Package will overhaul regulatory exclusivity, orphan drug incentives, antimicrobial innovation, and generic entry pathways, reducing standard protection periods while introducing new rewards like transferable exclusivity vouchers.
#
Patenting
​
Beyond CRISPR: Precision to Platform
23 January 2026
Gene editing is entering a new phase, moving beyond CRISPR-Cas9’s breakthrough but costly, bespoke therapies toward more precise and scalable platforms. While CRISPR-based treatments like Casgevy have proven clinical success, they remain expensive and entangled in ongoing patent disputes over foundational IP. Next-generation tools such as base editing and prime editing avoid double-strand DNA breaks, enabling more accurate corrections and broader therapeutic potential. The field’s focus is now shifting to disease-agnostic platforms that can be adapted across many conditions, improving access and efficiency.
#
Patenting
​
Confidentiality at the UPC: What litigants need to know
21 January 2026
This article explains how the Unified Patent Court approaches confidentiality in litigation, outlining the procedures for restricting access to sensitive information, how confidentiality clubs are formed, and when hearings may be held in private. It highlights key case law shaping these rules, the balance between fair trial rights and protection of commercial data, and the penalties for breaches. Practical guidance is provided to help parties navigate applications, manage confidential documents, and understand what to expect throughout UPC proceedings.
#
Litigation
​
EPO fees are going up in April 2026: Plan ahead now
19 January 2026
The European Patent Office will introduce a fee increase of roughly 5% from 1 April 2026, affecting search, examination, designation and renewal fees. Filing, excess page, opposition and appeal fees remain unchanged. Some costs—such as renewal fees—can be paid up to three months early, allowing applicants to secure the current lower rates. EIP recommends reviewing your portfolio ahead of the deadline.
#
Patenting
​
The contentious role of intellectual property in cryptographic standardisation
12 January 2026
This article explores how intellectual property rights affect the development and adoption of post-quantum cryptography standards. It highlights NIST’s proactive approach to patent licensing for new algorithms, reviews historical cases like RSA and ECC, and discusses the importance of clear IP terms for widespread cryptographic adoption.
#
Patenting
​
System architecture in quantum computing – history repeating itself?
24 December 2025
This article explores the evolution of system architecture in quantum computing, drawing parallels with the early days of classical computing. It discusses the current challenges in quantum hardware, the emergence of quantum instruction set architectures (ISAs), and the potential for a RISC vs. CISC debate similar to that in classical computing. The piece highlights opportunities for innovation and intellectual property, suggesting that the choices made now could shape the future landscape of quantum technologies and licensing.
#
Patenting
​
Strategic licensing: Turning IP into commercial value
09 December 2025
In today’s competitive landscape, effective commercial licensing strategies are essential for unlocking the full value of intellectual property. This article explores four critical pillars: understanding intellectual property as a property right, the fundamentals of licensing intellectual property rights, structuring successful joint ventures and best practices for intellectual property rights management. Whether you’re navigating new markets or scaling established innovations, these tips provide a roadmap for protecting, leveraging and maximizing your IP assets.
#
Consulting
​
The people, physics and patents of the 2025 Nobel prize
09 December 2025
The 2025 Nobel Prize in Physics recognised John Clarke, Michel H. Devoret, and John M. Martinis for proving macroscopic quantum tunnelling in electric circuits, a breakthrough that enabled quantum computing. Their pioneering research led to hundreds of patents, including innovations in MRI and quantum technology, highlighting the real-world impact of their discoveries.
#
Patenting
​
Vision 2035: The need for Innovation to meet ambitious targets set by the UK’s new critical minerals strategy
03 December 2025
The UK’s Critical Minerals Strategy 2025 sets ambitious targets to secure essential minerals for key industries by boosting domestic production, recycling, and innovation. The article highlights the vital role of intellectual property (IP) in supporting technological advances, encouraging collaboration, and strengthening the UK’s supply chains for a sustainable future.
#
Consulting
​
Research underlying Nobel prize in chemistry has sparked innovation and patent filings
02 December 2025
The 2025 Nobel Prize in Chemistry recognised the creators of metal-organic frameworks (MOFs), innovative materials with huge potential for water harvesting, clean energy, and environmental solutions. Their work has sparked a surge in global patent activity and new industrial application.
#
Patenting
​
UKIPO fee increases from April 2026: What it means for your IP strategy
25 November 2025
Provisional and interim injunctions both refer to temporary court orders granted before a full trial, aimed at preserving the status quo or preventing harm. In UK law, “interim injunction” is the standard term, while “provisional injunction” is less common and typically used in international contexts. Both serve the same purpose: urgent relief until the case is fully heard.
#
Patenting
​
Sustainable models: content licensing for generative AI training
21 November 2025
It is fair to say that no technology in recent times has created so much excitement and controversy as generative AI, and in particular Large Language Models (LLMs). Generative AI companies and their backers have their sights on generating billions, if not trillions of dollars, directly or indirectly from their models. Models which, in the vast majority of cases, are trained on original works without permission from, or payment to, their authors. The works used for training are primarily obtained by scraping the open web, a uniquely vast repository of publicly accessible knowledge and information, constantly updated to reflect the latest developments in human knowledge and culture.
#
Consulting
​
What should you look to protect in a (bio)pharma IP strategy?
18 November 2025
#
Patenting
​
Trade Secrets: Navigating geopolitical risks and IP theft in the semiconductor industry
04 November 2025
Semiconductors have always been a critical technology but have grown significantly in strategic importance in recent years. They have become the key building block in developing and existing markets, including quantum computing, edge computing, AI, IoT, automotive, cellular data technology, smartphones, robotics, and many more. The complex designs and innovations that power semiconductor manufacturing are invaluable both to the world’s economy and technological advancement. Consequently, the semiconductor industry has found itself at the centre of geopolitical tensions, especially between the United States and China. It has become a prime target for cyberattacks and intellectual-property (IP) theft. As such, companies operating in this area must be more vigilant in protecting their intellectual assets.
#
Consulting
​
UPC takes strict approach on costs reimbursement
30 October 2025
Insulet v. EOFlow UPC_CFI_773/2025 and UPC_CFI 774/2025 (Milan CD), decision of 15 October 2025[1] The dispute began when Insulet sought a provisional injunction against EOFlow to prevent...
#
Litigation
​